For in-house purification of up to 100 mg endotoxin-free ultrapure plasmid DNA
Features
and benefitsThe QIAGEN Ultrapure 100 Column (see figure "QIAGEN Ultrapure 100 Column") is designed for fast and efficient purification of up to 100 mg plasmid DNA. The system uses QIAGEN anion-exchange technology with integrated endotoxin removal to yield ultrapure DNA.

The bacterial biomass is lysed under alkaline conditions and the lysate is cleared by centrifugation (see flowchart). Endotoxins are removed using the special Endotoxin Removal Buffer, and the lysate is loaded onto the Ultrapure 100 Column for DNA purification using QIAGEN Anion-Exchange Resin.
The Ultrapure 100 Buffer Set provides buffers that are certified to contain <10 EU/ml (as determined by the BioWhittaker Kinetic-QCL Test) for use with the column. The Ultrapure 100 Column is delivered with a detailed protocol, and direct technical support is provided on request. A centrifuge and a peristaltic pump capable of flow rates up to 20 ml/min or FPLC are needed to operate the system.
The Ultrapure 100 Column yields plasmid DNA of a purity at least equivalent to that obtained after 2x CsCl-gradient centrifugation (see table "Comparison of ultrapure plasmid preparation technologies", reference 2). The simple endotoxin-removal step ensures that the purified DNA contains <0.1 EU/µg DNA. The DNA is therefore ideal for transfection, gene therapy research (1), and other sensitive applications.
Comparison of ultrapure plasmid preparation technologies
| 2x CsCl gradient centrifugation | QIAGEN Ultrapure 100 system | |
|
|
||
| Yield | 100 µg ¨C 5 mg DNA | Up to 100 mg DNA |
| DNA quality | High | Equal or better than 2x CsCl |
| Endotoxin removal | Additional extraction steps required | Integrated into chromatographic process |
| Toxic chemicals | CsCl, ethidium bromide, phenol, chloroform | None |
| DNA-damaging agents | UV light, toxic reagents | None |
| Centrifuge required | High-speed ultracentrifuge | Conventional centrifuge |
1. Le Borgne, S. et al. (1998) In vivo induction of specific cytotoxic T lymphocytes in mice and Rhesus macaques immunized with a DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology 240, 304.
2. Schorr, J. et al. (1995) Plasmid DNA for human gene therapy and DNA vaccines. Annals New York Acad. Sci. 772, 271.
¡¡
|
Note:The Ultrapure 100 Column and Buffer Set are not available in all countries. A deposit is required on the column. QIAGEN cannot accept Ultrapure 100 Columns that have been used in L2¨CL4/S2¨CS4 containment facilities. |